Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The thyroid hormone biosynthesis machinery is a complex, multi-component system of enzymes and transporters primarily located in the thyroid follicular cells, dedicated to the production of the essential metabolic hormones thyroxine (T4) and triiodothyronine (T3) [1, 3]. This machinery includes the sodium-iodide symporter (NIS) for active iodide uptake, pendrin for iodide transport into the follicular lumen, and thyroglobulin, which serves as the protein scaffold for hormone synthesis [7, 12, 14]. The central enzyme, thyroid peroxidase (TPO), catalyzes the oxidation of iodide and its subsequent attachment to tyrosyl residues on thyroglobulin, a process known as organification, followed by the coupling of iodotyrosines to form T4 and T3 [3, 6, 14]. This entire process is stimulated by thyroid-stimulating hormone (TSH) and is subject to autoregulation based on iodine availability [12, 14]. Dysfunctions in this machinery, whether due to autoimmune attack (e.g., Graves' disease) or genetic mutations, result in significant metabolic disorders like hyperthyroidism or congenital hypothyroidism [5, 9, 15]. Therapeutic strategies target specific components of this machinery, such as using thionamides to inhibit TPO or radioactive iodine to target the NIS for the treatment of overactive thyroid states [11, 18].
Inhibition of thyroid peroxidase (TPO) to prevent iodide organification and coupling [11, 18]; inhibition of the sodium-iodide symporter (NIS) to block iodide uptake [18]; and competitive inhibition of iodide transport [18].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroid hormone biosynthesis machinery.